Surmodics, Inc. (SRDX)
USD 29.25
(-2.86%)
USD 29.25
(-2.86%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 | -11.54 Million USD | -651.43% |
| 2023 | -1.53 Million USD | 94.37% |
| 2022 | -27.27 Million USD | -743.71% |
| 2021 | 4.23 Million USD | 277.29% |
| 2020 | 1.12 Million USD | -85.21% |
| 2019 | 7.59 Million USD | 270.34% |
| 2018 | -4.45 Million USD | -213.53% |
| 2017 | 3.92 Million USD | -60.68% |
| 2016 | 9.98 Million USD | -25.75% |
| 2015 | 13.44 Million USD | 11.77% |
| 2014 | 12.03 Million USD | -20.68% |
| 2013 | 15.16 Million USD | 48.25% |
| 2012 | 10.23 Million USD | 180.07% |
| 2011 | -12.77 Million USD | 39.41% |
| 2010 | -21.08 Million USD | -156.16% |
| 2009 | 37.55 Million USD | 154.77% |
| 2008 | 14.73 Million USD | 340.5% |
| 2007 | 3.34 Million USD | -83.54% |
| 2006 | 20.33 Million USD | 346.59% |
| 2005 | -8.24 Million USD | -210.89% |
| 2004 | 7.43 Million USD | -46.64% |
| 2003 | 13.93 Million USD | 78.76% |
| 2002 | 7.79 Million USD | 52.59% |
| 2001 | 5.1 Million USD | 20.5% |
| 2000 | 4.24 Million USD | -3.64% |
| 1999 | 4.4 Million USD | 175.0% |
| 1998 | 1.6 Million USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | 247 Thousand USD | 131.42% |
| 2024 Q3 | -7.55 Million USD | -3158.3% |
| 2024 Q1 | -786 Thousand USD | -111.74% |
| 2023 Q1 | -7.84 Million USD | 46.75% |
| 2023 FY | -1.53 Million USD | 94.37% |
| 2023 Q3 | 7.34 Million USD | 195.0% |
| 2023 Q2 | -7.73 Million USD | 1.4% |
| 2023 Q4 | 6.69 Million USD | -8.88% |
| 2022 Q1 | -2.81 Million USD | -873.01% |
| 2022 Q2 | -4.08 Million USD | -45.2% |
| 2022 FY | -27.27 Million USD | -743.71% |
| 2022 Q3 | -5.65 Million USD | -38.4% |
| 2022 Q4 | -14.72 Million USD | -160.63% |
| 2021 FY | 4.23 Million USD | 277.29% |
| 2021 Q3 | -3.28 Million USD | -140.65% |
| 2021 Q2 | 8.08 Million USD | 3051.46% |
| 2021 Q1 | -274 Thousand USD | 90.7% |
| 2021 Q4 | -289 Thousand USD | 91.21% |
| 2020 Q4 | -2.94 Million USD | -219.8% |
| 2020 Q1 | 148 Thousand USD | -95.84% |
| 2020 Q2 | 1.46 Million USD | 887.84% |
| 2020 FY | 1.12 Million USD | -85.21% |
| 2020 Q3 | 2.45 Million USD | 68.19% |
| 2019 Q3 | 1.46 Million USD | 16.16% |
| 2019 Q1 | 1.31 Million USD | 174.73% |
| 2019 Q2 | 1.26 Million USD | -3.66% |
| 2019 FY | 7.59 Million USD | 270.34% |
| 2019 Q4 | 3.55 Million USD | 142.43% |
| 2018 Q4 | -1.75 Million USD | 34.64% |
| 2018 FY | -4.45 Million USD | -213.53% |
| 2018 Q2 | 1.53 Million USD | 198.59% |
| 2018 Q1 | -1.55 Million USD | -489.0% |
| 2018 Q3 | -2.68 Million USD | -274.84% |
| 2017 FY | 3.92 Million USD | -60.68% |
| 2017 Q4 | 400 Thousand USD | -44.44% |
| 2017 Q3 | 720 Thousand USD | 42.29% |
| 2017 Q2 | 506 Thousand USD | -78.0% |
| 2017 Q1 | 2.3 Million USD | -13.01% |
| 2016 Q1 | 2.51 Million USD | -12.07% |
| 2016 Q3 | 4 Million USD | 385.21% |
| 2016 Q2 | 825 Thousand USD | -67.17% |
| 2016 Q4 | 2.64 Million USD | -33.95% |
| 2016 FY | 9.98 Million USD | -25.75% |
| 2015 Q3 | 3.92 Million USD | 28.61% |
| 2015 Q4 | 2.85 Million USD | -27.17% |
| 2015 Q1 | 3.61 Million USD | 54.18% |
| 2015 FY | 13.44 Million USD | 11.77% |
| 2015 Q2 | 3.05 Million USD | -15.58% |
| 2014 Q3 | 3.59 Million USD | 46.32% |
| 2014 Q1 | 3.63 Million USD | -1.52% |
| 2014 FY | 12.03 Million USD | -20.68% |
| 2014 Q2 | 2.45 Million USD | -32.26% |
| 2014 Q4 | 2.34 Million USD | -34.85% |
| 2013 Q3 | 3.13 Million USD | -23.67% |
| 2013 Q1 | 4.24 Million USD | 55.04% |
| 2013 Q4 | 3.68 Million USD | 17.73% |
| 2013 Q2 | 4.1 Million USD | -3.44% |
| 2013 FY | 15.16 Million USD | 48.25% |
| 2012 Q1 | 2.7 Million USD | 120.92% |
| 2012 FY | 10.23 Million USD | 180.07% |
| 2012 Q4 | 2.74 Million USD | -10.52% |
| 2012 Q3 | 3.06 Million USD | 77.71% |
| 2012 Q2 | 1.72 Million USD | -36.33% |
| 2011 FY | -12.77 Million USD | 39.41% |
| 2011 Q3 | 3.84 Million USD | 54.42% |
| 2011 Q2 | 2.48 Million USD | 759.95% |
| 2011 Q4 | -12.93 Million USD | -436.73% |
| 2011 Q1 | -377 Thousand USD | 98.26% |
| 2010 FY | -21.08 Million USD | -156.16% |
| 2010 Q3 | -916 Thousand USD | -114.52% |
| 2010 Q4 | -21.66 Million USD | -2264.96% |
| 2010 Q2 | -427 Thousand USD | -122.27% |
| 2010 Q1 | 1.91 Million USD | -29.26% |
| 2009 Q3 | 3.53 Million USD | -16.06% |
| 2009 Q1 | 27.08 Million USD | 3427.4% |
| 2009 Q2 | 4.21 Million USD | -84.43% |
| 2009 FY | 37.55 Million USD | 154.77% |
| 2009 Q4 | 2.71 Million USD | -23.42% |
| 2008 Q1 | 5.64 Million USD | 140.6% |
| 2008 FY | 14.73 Million USD | 340.5% |
| 2008 Q4 | -814 Thousand USD | -116.96% |
| 2008 Q3 | 4.8 Million USD | -6.01% |
| 2008 Q2 | 5.1 Million USD | -9.55% |
| 2007 Q1 | 5.99 Million USD | -4.8% |
| 2007 FY | 3.34 Million USD | -83.54% |
| 2007 Q4 | -13.9 Million USD | -348.92% |
| 2007 Q3 | 5.58 Million USD | -1.55% |
| 2007 Q2 | 5.67 Million USD | -5.29% |
| 2006 FY | 20.33 Million USD | 346.59% |
| 2006 Q1 | 6.21 Million USD | 29.76% |
| 2006 Q2 | 1.46 Million USD | -76.44% |
| 2006 Q3 | 6.35 Million USD | 333.99% |
| 2006 Q4 | 6.29 Million USD | -1.01% |
| 2005 FY | -8.24 Million USD | -210.89% |
| 2005 Q4 | 4.79 Million USD | -21.38% |
| 2005 Q3 | 6.09 Million USD | 125.01% |
| 2005 Q2 | -24.37 Million USD | -528.92% |
| 2005 Q1 | 5.68 Million USD | 4.39% |
| 2004 FY | 7.43 Million USD | -46.64% |
| 2004 Q4 | 5.44 Million USD | 183.85% |
| 2004 Q1 | 4.11 Million USD | -7.47% |
| 2004 Q2 | 4.37 Million USD | 6.35% |
| 2004 Q3 | -6.49 Million USD | -248.47% |
| 2003 Q3 | 4.57 Million USD | 66.25% |
| 2003 Q2 | 2.75 Million USD | 26.67% |
| 2003 Q1 | 2.17 Million USD | -16.4% |
| 2003 Q4 | 4.44 Million USD | -2.82% |
| 2003 FY | 13.93 Million USD | 78.76% |
| 2002 FY | 7.79 Million USD | 52.59% |
| 2002 Q4 | 2.59 Million USD | 27.87% |
| 2002 Q3 | 2.03 Million USD | 15.53% |
| 2002 Q2 | 1.75 Million USD | 24.68% |
| 2002 Q1 | 1.41 Million USD | 152.24% |
| 2001 Q1 | 1.36 Million USD | -10.84% |
| 2001 FY | 5.1 Million USD | 20.5% |
| 2001 Q4 | 559 Thousand USD | -65.45% |
| 2001 Q3 | 1.61 Million USD | 3.32% |
| 2001 Q2 | 1.56 Million USD | 14.64% |
| 2000 Q2 | 904 Thousand USD | 0.44% |
| 2000 Q1 | 900 Thousand USD | -25.0% |
| 2000 FY | 4.24 Million USD | -3.64% |
| 2000 Q4 | 1.53 Million USD | 77.93% |
| 2000 Q3 | 861 Thousand USD | -4.76% |
| 1999 Q1 | 900 Thousand USD | 80.0% |
| 1999 Q3 | 1.2 Million USD | 9.09% |
| 1999 Q2 | 1.1 Million USD | 22.22% |
| 1999 FY | 4.4 Million USD | 175.0% |
| 1999 Q4 | 1.2 Million USD | 0.0% |
| 1998 FY | 1.6 Million USD | 0.0% |
| 1998 Q4 | 500 Thousand USD | -16.67% |
| 1998 Q2 | 400 Thousand USD | 300.0% |
| 1998 Q1 | 100 Thousand USD | 0.0% |
| 1998 Q3 | 600 Thousand USD | 50.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | -61.61 Million USD | 81.268% |
| BrainsWay Ltd. | -4.19 Million USD | -175.006% |
| Cerus Corporation | -37.48 Million USD | 69.212% |
| Envoy Medical, Inc. | -29.9 Million USD | 61.408% |
| electroCore, Inc. | -18.83 Million USD | 38.717% |
| Helius Medical Technologies, Inc. | -8.85 Million USD | -30.418% |
| IceCure Medical Ltd | -14.65 Million USD | 21.226% |
| Inogen, Inc. | -102.44 Million USD | 88.734% |
| OrthoPediatrics Corp. | -20.97 Million USD | 44.97% |
| Lucid Diagnostics Inc. | -52.66 Million USD | 78.085% |
| Monogram Orthopaedics, Inc. | -13.74 Million USD | 16.029% |
| MaxCyte, Inc. | -37.92 Million USD | 69.565% |
| NeuroOne Medical Technologies Corporation | -11.85 Million USD | 2.677% |
| Nexalin Technology, Inc. | -4.64 Million USD | -148.284% |
| Orthofix Medical Inc. | -151.39 Million USD | 92.376% |
| PAVmed Inc | -64.17 Million USD | 82.015% |
| Rapid Micro Biosystems, Inc. | -52.46 Million USD | 78.001% |
| RxSight, Inc. | -48.6 Million USD | 76.255% |
| Sight Sciences, Inc. | -55.54 Million USD | 79.221% |
| SI-BONE, Inc. | -43.33 Million USD | 73.366% |
| TELA Bio, Inc. | -46.66 Million USD | 75.266% |
| Treace Medical Concepts, Inc. | -49.52 Million USD | 76.696% |
| Vivos Therapeutics, Inc. | -13.58 Million USD | 15.026% |
| Acutus Medical, Inc. | -81.66 Million USD | 85.866% |
| Talis Biomedical Corporation | -62 Million USD | 81.386% |
| Spectral AI, Inc. | -20.85 Million USD | 44.653% |
| Nano-X Imaging Ltd. | -60.77 Million USD | 81.009% |
| CVRx, Inc. | -41.19 Million USD | 71.985% |
| DIH Holding US, Inc. Warrants | 640.19 Thousand USD | 1902.885% |
| PetVivo Holdings, Inc. | -10.95 Million USD | -5.355% |
| Bioventus Inc. | -156.23 Million USD | 92.612% |
| Venus Concept Inc. | -37.25 Million USD | 69.015% |
| TriSalus Life Sciences, Inc. | -59.03 Million USD | 80.45% |
| LivaNova PLC | 17.54 Million USD | 165.781% |
| 908 Devices Inc. | -36.39 Million USD | 68.29% |
| Alphatec Holdings, Inc. | -186.63 Million USD | 93.816% |
| Nemaura Medical Inc. | -14.14 Million USD | 18.395% |
| NeuroPace, Inc. | -32.95 Million USD | 64.978% |
| LENSAR, Inc. | -14.38 Million USD | 19.752% |
| Apyx Medical Corporation | -18.71 Million USD | 38.321% |
| Cutera, Inc. | -162.83 Million USD | 92.912% |
| STRATA Skin Sciences, Inc. | -10.83 Million USD | -6.574% |
| BioSig Technologies, Inc. | -29.04 Million USD | 60.256% |
| Anika Therapeutics, Inc. | -82.66 Million USD | 86.038% |
| ClearPoint Neuro, Inc. | -22.08 Million USD | 47.748% |
| Integra LifeSciences Holdings Corporation | 67.74 Million USD | 117.038% |
| Axonics, Inc. | -6.08 Million USD | -89.586% |
| Outset Medical, Inc. | -172.79 Million USD | 93.32% |
| IRIDEX Corporation | -9.57 Million USD | -20.606% |
| PROCEPT BioRobotics Corporation | -105.89 Million USD | 89.101% |
| IRadimed Corporation | 17.19 Million USD | 167.133% |
| Tivic Health Systems, Inc. | -8.24 Million USD | -40.005% |
| INVO Bioscience, Inc. | -8.03 Million USD | -43.653% |
| Telesis Bio, Inc. | -47.72 Million USD | 75.815% |
| Viemed Healthcare, Inc. | 10.24 Million USD | 212.682% |
| Varex Imaging Corporation | -47.7 Million USD | 75.803% |
| Quipt Home Medical Corp. | -2.78 Million USD | -314.583% |
| Inspira Technologies Oxy B.H.N. Ltd. | -11.28 Million USD | -2.268% |
| Pulmonx Corporation | -60.84 Million USD | 81.03% |
| Dynatronics Corporation | -2.69 Million USD | -327.843% |
| Modular Medical, Inc. | -17.47 Million USD | 33.932% |
| ReShape Lifesciences Inc. | -11.38 Million USD | -1.361% |
| Semler Scientific, Inc. | 20.58 Million USD | 156.075% |
| InMode Ltd. | 197.91 Million USD | 105.832% |
| Bruker Corporation | 427.2 Million USD | 102.702% |
| Cytosorbents Corporation | -28.5 Million USD | 59.512% |
| DexCom, Inc. | 541.5 Million USD | 102.131% |
| Align Technology, Inc. | 445.05 Million USD | 102.593% |
| Viveve Medical, Inc. | -22.02 Million USD | 47.601% |
| ZimVie Inc. | -393.28 Million USD | 97.065% |
| Movano Inc. | -29.28 Million USD | 60.585% |
| Cytek Biosciences, Inc. | -12.14 Million USD | 4.988% |
| Nexalin Technology, Inc. | -4.64 Million USD | -148.284% |
| DIH Holdings US, Inc. Class A Common Stock | 640.19 Thousand USD | 1902.885% |
| Tandem Diabetes Care, Inc. | -222.61 Million USD | 94.815% |
| Profound Medical Corp. | -28.56 Million USD | 59.6% |
| Insulet Corporation | 206.3 Million USD | 105.595% |
| enVVeno Medical Corporation | -23.51 Million USD | 50.919% |
| iCAD, Inc. | -4.84 Million USD | -138.127% |
| Nuwellis, Inc. | -20.2 Million USD | 42.887% |
| Biotricity, Inc. | -14.09 Million USD | 18.109% |
| iRhythm Technologies, Inc. | -123.4 Million USD | 90.647% |
| Aethlon Medical, Inc. | -12.2 Million USD | 5.457% |
| InspireMD, Inc. | -19.91 Million USD | 42.047% |
| PAVmed Inc. | -64.17 Million USD | 82.015% |
| BIOLASE, Inc. | -20.63 Million USD | 44.058% |
| Beyond Air, Inc. | -60.24 Million USD | 80.841% |
| FONAR Corporation | 10.56 Million USD | 209.223% |
| AxoGen, Inc. | -21.71 Million USD | 46.85% |
| Vivani Medical, Inc. | -25.65 Million USD | 55.005% |
| Tactile Systems Technology, Inc. | 28.51 Million USD | 140.477% |
| Inari Medical, Inc. | -1.63 Million USD | -605.501% |
| UFP Technologies, Inc. | 44.92 Million USD | 125.692% |
| QT Imaging Holdings, Inc. | -5.13 Million USD | -124.888% |
| Heart Test Laboratories, Inc. | -6.6 Million USD | -74.741% |
| Tenon Medical, Inc. | -15.58 Million USD | 25.923% |
| Autonomix Medical, Inc. Common Stock | -15.42 Million USD | 25.178% |
| Co-Diagnostics, Inc. | -35.33 Million USD | 67.334% |
| AdaptHealth Corp. | -678.89 Million USD | 98.3% |
| Sintx Technologies, Inc. | -8.25 Million USD | -39.751% |
| NanoVibronix, Inc. | -3.71 Million USD | -211.021% |
| Quanterix Corporation | -32.33 Million USD | 64.304% |
| Inspira Technologies Oxy B.H.N. Ltd. | -11.28 Million USD | -2.268% |
| Sensus Healthcare, Inc. | 485 Thousand USD | 2479.794% |
| Pacific Biosciences of California, Inc. | -306.73 Million USD | 96.237% |
| TransMedics Group, Inc. | -25.02 Million USD | 53.884% |
| ReWalk Robotics Ltd. | -22.13 Million USD | 47.852% |
| NeuroMetrix, Inc. | -6.52 Million USD | -76.767% |
| Hyperfine, Inc. | -44.23 Million USD | 73.909% |
| Establishment Labs Holdings Inc. | -78.5 Million USD | 85.297% |
| Biomerica, Inc. | -5.97 Million USD | -93.075% |
| Bone Biologics Corporation | -8.94 Million USD | -28.979% |
| AVITA Medical, Inc. | -39.16 Million USD | 70.532% |
| Bluejay Diagnostics, Inc. | -9.95 Million USD | -15.955% |
| Silk Road Medical, Inc | -55.74 Million USD | 79.294% |